Kort præsentation

Experienced leader with many years of management in the cutting-edge fields of cell therapy and gene editing (viral- and non-viral). Passionate about driving innovation and transforming healthcare through groundbreaking technologies (TIL-therapy, CAR-T therapy). Proven track record of guiding cross-functional teams, fostering collaboration, and successfully navigating complex regulatory landscapes. Committed to advancing the frontiers of science and delivering life-changing treatments to patients in need.

Primære forskningsområder

With a substantial tenure in research spanning many years, my primary area of expertise focus on translational research, bridging the gap between scientific discovery and practical application. My research is primarily oriented toward adoptive cell therapy, with a particular emphasis on T cells and lineage differentiated immune cells.
In addition to advancing scientific knowledge, I am actively involved in technology transfer, facilitating the seamless transition of research findings from the laboratory bench to clinical implementation. Gene editing technology (viral and non-viral) has been a pivotal tool in my work, allowing for innovative approaches in T-cell immunotherapy and precision medicine.
Throughout my career, I have demonstrated a commitment to project development, ensuring that research efforts lead to tangible benefits for patients. My dedication to the bench-to-bedside journey, coupled with a keen focus on gene editing and immunotherapy, underscores my commitment to making a meaningful impact in the field of translational research.

Aktuel forskning